|Articles|February 1, 1998

February 1998
Volume 4
Issue 2

Menopause and Controversies in Hormone Replacement Therapy

Author(s)Ilana Cass, MD, Carolyn D. Runowicz, MD

Download PDF: Menopause and Controversies in Hormone Replacement Therapy

Articles in this issue

over 28 years ago

Article

Physicians' Perceptions of Managed Care

over 28 years ago

Article

The Impact of a Simulated Immunization Registry on Perceived Childhood Immunization Status

over 28 years ago

Article

Outcomes for Control Patients Referred to a Pediatric Asthma Outreach Program: An Example of the Hawthorne Effect

over 28 years ago

Article

Effect of Compensation Method on the Behavior of Primary Care Physicians in Managed Care Organizations: Evidence from Interviews with Physicians and Medical Leaders in Washington State

over 28 years ago

Article

The Pharmacoeconomic Benefits of Cholesterol Reduction

over 28 years ago

Article

Differential Effects of Inhaled Corticosteroids: Fluticasone Propionate Versus Triamcinolone Acetonide

over 28 years ago

Article

The Neonatologist as Primary Care Physician

over 28 years ago

Article

An Update on the Treatment of Premenstrual Syndrome

over 28 years ago

Article

Physicians' Perceptions of Managed Care

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Menopause and Controversies in Hormone Replacement Therapy

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

Medicaid MFN Pricing Could Save $8.6 Billion

Cardiology Prices Vary Widely by Insurer and State

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

Active US Drug Shortages Rise for Third Straight Quarter

Hepatitis Prevention Programs Improve Liver Outcomes, but Gaps in Screening, Care Remain